CTNI-61. CLINICAL EFFICACY AND PREDICTIVE BIOMARKERS OF ONC201 IN H3K27M-MUTANT DIFFUSE MIDLINE GLIOMA Article

Kawakibi, Abed Rahman, Tarapore, Rohinton, Gardner, Sharon et al. (2022). CTNI-61. CLINICAL EFFICACY AND PREDICTIVE BIOMARKERS OF ONC201 IN H3K27M-MUTANT DIFFUSE MIDLINE GLIOMA . NEURO-ONCOLOGY, 24(Supplement_7), vii86-vii87. 10.1093/neuonc/noac209.326

cited authors

  • Kawakibi, Abed Rahman; Tarapore, Rohinton; Gardner, Sharon; Chi, Andrew; Kurz, Sylvia; Wen, Patrick Y; Arrillaga-Romany, Isabel; Batchelor, Tracy; Butowski, Nicholas; Sumrall, Ashley; Shonka, Nicole; Harrison, Rebecca; DeGroot, John; Mehta, Minesh; Odia, Yazmin; Hall, Matthew; Daghistani, Doured; Cloughesy, Timothy; Ellingson, Benjamin; Kim, Michelle; Umemura, Yoshie; Garton, Hugh; Franson, Andrea; Schwartz, Jonathan; Li, Sunjong; Cartaxo, Rodrigo; Ravi, Karthik; Cantor, Evan; Cummings, Jessica; Paul, Alyssa; Walling, Dustin; Dun, Matthew; Cain, Jason; Li, Jiang; Filbin, Mariella; Zhao, Lili; Kumar-Sinha, Chandan; Mody, Rajen; Chinnaiyan, Arul; Kurokawa, Ryo; Pratt, Drew; Venneti, Sriram; Grill, Jacques; Kline, Cassie; Mueller, Sabine; Resnick, Adam C; Nazarian, Javad; Waszak, Sebastian; Allen, Joshua E; Koschmann, Carl

authors

publication date

  • November 14, 2022

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3202 Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • 6.1 Pharmaceuticals
  • Brain Cancer
  • Brain Disorders
  • Cancer
  • Clinical Research
  • Clinical Trials and Supportive Activities
  • Genetics
  • Health Disparities
  • Human Genome
  • Minority Health
  • Neurosciences
  • Rare Diseases

Digital Object Identifier (DOI)

publisher

  • Oxford University Press (OUP)

start page

  • vii86

end page

  • vii87

volume

  • 24

issue

  • Supplement_7